PMID: 15377480Sep 21, 2004Paper

Granulocyte colony-stimulating factor after autologous CD34+ immunoselected peripheral blood stem cell transplantation

Haematologica
Nicola PiccirilloSimona Sica

Abstract

Granulocyte colony-stimulating factor (G-CSF) can be administered after a peripheral blood stem cell transplantation with the aim of accelerating neutrophil recovery. In a randomized, single-blind study we studied a new administration schedule of G-CSF in this context.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.